Mario Alberto Accardi's Rule 10b5-1 Trading Plan for Centessa Pharmaceuticals

Mario Alberto Accardi, an officer of Centessa Pharmaceuticals plc, has filed a Form 144 to report transactions under a Rule 10b5-1 trading plan. The plan, adopted on February 14, 2025, involves the sale of 8,000 common shares acquired as Founders Shares on January 2, 2020. The approximate sale date is October 27, 2025, with an aggregate market value of $200,000. Additionally, Accardi has sold a total of 38,494 common shares in the past three months, generating gross proceeds of $651,597.20. The transactions were executed through UBS Financial Services, Inc. This filing highlights significant insider trading activity, which could impact investor sentiment and the stock's performance.